Rudick RA - Search Results

1

Magnetic resonance imaging lesion enlargement in multiple sclerosis. Disease-related activity, chance occurrence, or measurement artifact?

Goodkin DE, Ross JS, Medendorp SV, Konecsni J, Rudick RA. Goodkin DE, et al. Among authors: rudick ra. Arch Neurol. 1992 Mar;49(3):261-3. doi: 10.1001/archneur.1992.00530270075021. Arch Neurol. 1992. PMID: 1536628

2

Axonal transection in the lesions of multiple sclerosis.

Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mörk S, Bö L. Trapp BD, et al. N Engl J Med. 1998 Jan 29;338(5):278-85. doi: 10.1056/NEJM199801293380502. N Engl J Med. 1998. PMID: 9445407 Free article.

3

Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Trapp BD, Ransohoff R, Rudick R. Trapp BD, et al. Curr Opin Neurol. 1999 Jun;12(3):295-302. doi: 10.1097/00019052-199906000-00008. Curr Opin Neurol. 1999. PMID: 10499174 Review.

4

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.

Marrie RA, Rudick R, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Marrie RA, et al. Among authors: rudick r. Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125. Neurology. 2010. PMID: 20350978 Free PMC article.

5

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.

Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD. Bjartmar C, et al. Ann Neurol. 2000 Dec;48(6):893-901. Ann Neurol. 2000. PMID: 11117546

6

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1997 Sep;42(3):379-82. doi: 10.1002/ana.410420318. Ann Neurol. 1997. PMID: 9307263

7

Clinical outcomes assessment in multiple sclerosis.

Rudick R, Antel J, Confavreux C, Cutter G, Ellison G, Fischer J, Lublin F, Miller A, Petkau J, Rao S, Reingold S, Syndulko K, Thompson A, Wallenberg J, Weinshenker B, Willoughby E. Rudick R, et al. Ann Neurol. 1996 Sep;40(3):469-79. doi: 10.1002/ana.410400321. Ann Neurol. 1996. PMID: 8797541 Review.

8

Pregnancy and multiple sclerosis.

Birk K, Rudick R. Birk K, et al. Arch Neurol. 1986 Jul;43(7):719-26. doi: 10.1001/archneur.1986.00520070075022. Arch Neurol. 1986. PMID: 2425783 Review.

9

Pregnancy and multiple sclerosis.

Birk K, Smeltzer SC, Rudick R. Birk K, et al. Semin Neurol. 1988 Sep;8(3):205-13. doi: 10.1055/s-2008-1041379. Semin Neurol. 1988. PMID: 2461576 Review.

10

MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS.

Miller DH, Soon D, Fernando KT, MacManus DG, Barker GJ, Yousry TA, Fisher E, O'Connor PW, Phillips JT, Polman CH, Kappos L, Hutchinson M, Havrdova E, Lublin FD, Giovannoni G, Wajgt A, Rudick R, Lynn F, Panzara MA, Sandrock AW; AFFIRM Investigators. Miller DH, et al. Neurology. 2007 Apr 24;68(17):1390-401. doi: 10.1212/01.wnl.0000260064.77700.fd. Neurology. 2007. PMID: 17452584 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results